Sara Barnard, in Casselton, ND - Speech-Language Pathologist

Sara Barnard, is a Speech-language Pathologist based in Casselton, North Dakota. Sara Barnard is licensed to practice in North Dakota (license number 65816) and her current practice location is 802 5th St N, Casselton, North Dakota. She can be reached at her office (for appointments etc.) via phone at (701) 347-5353.

NPI number for Sara Barnard is 1417465519 and her current mailing address is 802 5th St N, Casselton, North Dakota. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1417465519.

Contact Information

	Sara Barnard,
	802 5th St N, Casselton, ND 58012-3346
	(701) 347-5353
	Not Available

Healthcare Provider's Profile

Full Name	Sara Barnard
Gender	Female
Speciality	Speech-language Pathologist
Location	802 5th St N, Casselton, North Dakota
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1417465519
Provider Enumeration Date: 01/11/2018
Last Update Date: 01/11/2018

Medical Identifiers

Medical identifiers for Sara Barnard such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1417465519	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	65816 (North Dakota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sara Barnard is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Sara Barnard, 802 5th St N, Casselton, ND 58012-3346 Ph: (701) 347-5353	Sara Barnard, 802 5th St N, Casselton, ND 58012-3346 Ph: (701) 347-5353

News Archive

Genetic fishing expedition yields surprising catch important to mammals

Johns Hopkins investigators report the discovery of master controllers of a gene critical to human and all mammalian development by trawling, implausibly enough, through anonymous genetic sequences using tiny zebrafish embryos.

MRI and blood test combination results in improved prostate cancer diagnosis

New research from Karolinska Institutet shows that the blood test Stockholm3 together with magnetic resonance imaging and targeted prostate biopsies may lead to a significant decrease in the number of biopsy procedures and diagnoses of harmless disease.

Ellex gets CE Mark approval for 2RT laser treatment of early stage AMD

Ellex Medical Lasers Limited, a pioneer in medical technologies for the diagnosis and treatment of eye disease, today announced that it has secured a CE Mark (Conformité Européenne) for its proprietary Retinal Rejuvenation Therapy (2RT) laser treatment of early Age-Related Macular Degeneration (AMD).

Study could lead to development of differential treatments for pain in men versus women

A study conducted by investigators at Georgia State University and the Atlanta-based Center for Behavioral Neuroscience (CBN) reports that anatomical and functional differences in the brain may explain sex differences in the experience of pain and in the effects of certain drugs on pain.

Sara Barnard, - Speech-Language Pathologist in Casselton, ND